View this video to hear Dr David A. Johnson share his insights into the treatment of gastroesophageal reflux disease (GERD). He reviews changes in epidemiology, nonoperative ablative techniques, the definition of GERD, the benefits of the dual peak delivery system of KAPIDEX™, and improved patient compliance through flexible dosing schedules. In addition, he offers his take on how new treatment strategies can continue and enhance the success of the proton-pump inhibitors.